Research Statement

Research Keywords

• Real world data analysis
• Health technology assessment
• Health policy and system research including health equity
• Health economic evaluation
• Global Health
• Evidence synthesis

Presentations

• Kategeaw W, Witt DM, King JB, Malone DC, Chaiyakunapruk N. Patient self-management for managing warfarin in patients with non-valvular atrial fibrillation in the US: A threshold analysis of cost-effectiveness analysis. 32nd Congress of the International Society on Thrombosis and Haemostasis. June 22-26, 2024, Bangkok, Thailand. Poster, Presented, 06/2024.
• Boonpattharatthiti K, Kategeaw W, Hong H, Dhippayom T, Chaiyakunapruk N, Witt DM. Comparative effectiveness of warfarin management strategies: A systematic review and network meta-analysis. 32nd Congress of the International Society on Thrombosis and Haemostasis. June 22-26, 2024; Bangkok, Thailand. Oral presentation (by Boonpattharatthiti K). Presentation, Presented, 06/2024.
• Schmutz H, Duong KNC, Ben-Umeh K, Duru E, Trom C, Rose N, Chaiyakunapruk N, Willis C. Comparative Effectiveness of Rapid Vs. Non-Rapid Start of Anti-Retroviral Therapy in Patients With Human Immunodeficiency Virus Infection on Clinical Outcomes: A Systematic Literature Review and Meta-Analysis. ISPOR 2024. May 5-8, 2024, Atlanta, Georgia, US. Poster, Presented, 05/2024.
• Duong KNC, Nguyen DT, Kategaew W, Liang X, Khaing W, Visnovsky LD, Veettil SK, McFarland MM, Nelson RE, Jones BE, Pavia AT, Coates E, Khader K, Love J, Vega Yon G, Zhang Y, Willson T, Dorsan E, Toth D, Jones MM, Samore MH, Chaiyakunapruk N. Incorporating Social Determinants of Health into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review. ISPOR US 2024. May 5-8, 2024, Atlanta, Georgia, US. Poster, Presented, 05/2024.
• Kategeaw W, Witt DM, King JB, Malone DC, Chaiyakunapruk N. Cost-Effectiveness Analysis of Patient Self-Management for Managing Warfarin in Patients with Non-Valvular Atrial Fibrillation in the US. ISPOR 2024. May 5-8, 2024, Atlanta, Georgia, US. Poster, Presented, 05/2024.
• Cho JY, Lee HS, Wannaadisai W, Vietri J, Chaiyakunapruk N. Systematic Literature Review of Cost-Effectiveness Analyses of Adult 15- and 20-Valent Pneumococcal Vaccines. ISPOR 2024. May 5-8, 2024, Atlanta, GA, USA. Poster, Presented, 05/2024.
• Nguyen D, Lee H, Chaiyakunapruk N. Cost-Effectiveness Analysis of Respiratory Syncytial Virus (RSV) Prevention Interventions in the United States. ISPOR US 2024. May 5-8, 2024, Atlanta, Geogia, US. Poster, Presented, 05/2024.
• Nguyen D, Duong K, Coates E, Nelson R, Love J, Jones M, Samore M, Chaiyakunapruk N, Toth D. Assessment of the effects of an equity-targeted vaccination outreach program on overall and distributional health and economic outcomes. ISPOR US 2024. May 5-8, 2024, Atlanta, Geogia, US. Podium Presentation (by Nguyen D). Presentation, Presented, 05/2024.
• Patikon C, Tan CJ, Cho JY, Khuntha S, Ha NT, Noviyani R, Gloria MAJ, Avanceña ALV, Shimamoto K, Youngkong S. Chaiyakunapruk N. Role of Health Equity in Health Technology Assessment in Asia: A Landscape Analysis of 13 Health Systems in Asia. The PMAC 2024 “Geopolitics, Human Security and Health Equity in an Era of Polycrises”. 25-27 January 2024 in Bangkok, Thailand. Poster, Presented, 01/2024.
• Danpanichkul P, Kongarin S, Srisurapanont K, Jaroenlapnopparat A, Sripusanapan A, Manosroi W, Polpichai N, Duangsonk K, Panpradist N, Chaiyakunapruk N, Mousa OY, Kim D, Chen VL, Wijarnpreecha K. Elderly MASLD in Asia-Pacific: A Trend From the Global Burden of Disease 2019. Dec 6-9, 2023, Bangkok, Thailand. Asia Pacific Digestive Week 2023. Oral Presentation. Presentation, Presented, 12/2023.
• Cho JY, Wilson FA, Chaikledkaew U, Phrommintikul A, Kim K, Chaiyakunapruk N. Economic evaluation of improving medication adherences for secondary cardiovascular disease prevention: a threshold analysis. ISPOR Europe 2023. Nov 12-15, 2023, Copenhagen, Denmark. Poster, Presented, 11/2023.
• Cho JH, Wilson FA, Chaikledkaew U, Phrommintikul A, Kim K, Chaiyakunapruk N. Projected cost saving with optimal medication adherence in cardiovascular disease patients requiring lipid lowering agents in Mexico and Thailand. American Heart Association’s annual meeting 2023. Nov 11-13, 2023, Philadelphia, PA.(Abstract number : 15092, presented by Cho JH). Poster, Presented, 11/2023.
• Patikorn C, Cho JY, Higashi J, Huang XX, Chaiyakunapruk N. Financial Hardship from Neglected Tropical Diseases: A Systematic Literature Review and Meta-Analysis. ISPOR Europe 2023. Nov 12-15, 2023, Copenhagen, Denmark. Poster presentation (Acceptance Code: HSD84). Poster, Presented, 11/2023.
• Drummond MF, Augustovski F, Chaiyakunapruk N. Reporting Economic Evaluations: How to Use CHEERS 2022. ISPOR Europe 2023. Nov 12-15, 2023, Copenhagen, Denmark. Short-course presentation. Presentation, Presented, 11/2023.
• Duong KNC, Schmutz HW, Ben-Umeh K, Duru E, Rose N, Trom C, Willis C, Chaiyakunapruk N. Summarizing the economic value of rapid start antiretroviral therapy in patients with HIV infections: a systematic literature review. AMCP Nexus 2023 Oct. 16-19, 2023. Orlando, FL, USA. (Silver Ribbon). Poster, Presented, 10/2023.
• Syeed S, Tan CJ, Godara A, Gooden K, Tang D, Slaff S, Ngorsuraches S, Shih YH, Chaiyakunapruk N. How do patients and providers value innovative multiple myeloma treatments? Evidence from a discrete choice experiment. The 2023 IMS (International Myeloma Society) Annual Meeting. Sept 27-30, 2023, Athens, Greece.(Abstract number : 1540828, presented by Syeed S). Poster, Presented, 09/2023.
• Patikorn C, Cho JY, Lambach P, Hutubessy R, Chaiyakunapruk N. How well do we consider equity in efficiency analysis studies of vaccines? A systematic review of equity-informative economic evaluations of vaccines. Cochrane Colloquium 2023. Sept 4-6, 2023. London, UK. Short Oral Presentation (Abstract number : 36593, presented by Chaiyakunapruk N). Presentation, Presented, 09/2023.
• Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, Veettil SK, Chaiyakunapruk N Effects of Ketogenic Diet on Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Clinical Trials. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 124963). Poster, Presented, 05/2023.
• Syeed MS, Nonthasawadsri T, Nelson RE, Chaiyakunapruk N, Nathisuwan S. Integrating Real-World Evidence in Economic Evaluation of Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation in a Developing Country. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 124544) . Poster, Presented, 05/2023.
• Duong KNC, Nguyen DV, Chaiyakunapruk N, Nelson RE, Malone DC. Pharmacogenetic HLA-B*58:01 testing to prevent allopurinol-induced SJS/TEN in Vietnamese population: a cost-effectiveness analysis. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 126193) . Poster, Presented, 05/2023.
• Nguyen D, Liang X, Veettil S, Tan CJ, Patikorn C, Nguyen S, Brixner D, Chaiyakunapruk N. The magnitude of the association between insulin adherence based on prescription fill rate measures and glycemic control: a systematic review and meta-analysis. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 126225). Poster, Presented, 05/2023.
• Kategeaw W, Nakkam N, Kiertiburanakul S, Sukasem C, Tassaneeyakul W, Chaiyakunapruk N. Cost-Effectiveness Analysis of HLA-B*13:01 Screening for the Prevention of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions among HIV-Infected Patients in Thailand. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 126225). Poster, Presented, 05/2023.
• Le LM, Duong KNC, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, Friedrichs M, Jones BE, Visnovsky L, Pavia AT, Jones MM, Samore MH, Chaiyakunapruk N. Disparities in COVID-19 related outcomes in the United States by race and ethnicity: an umbrella review of meta-analyses. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 124701) . Poster, Presented, 05/2023.
• Tan CJ, Tran TH, Patikorn C, Chaiyakunapruk N. Interventions to address healthcare disparities among cancer patients and survivors in the United States: A scoping review. ISPOR 2023. May 7-10, 2023. Boston, MA, USA. (Abstract ID 126261). Poster, Presented, 05/2023.
• Patikorn C, Kategeaw W, Perdrizet J, Li X, Chaiyakunapruk N. Implementation Challenges and Real-World Impacts of Switching Pediatric Vaccines: A Global Systematic Literature Review. ISPOR 2023. May 7-10, 2023. Boston, MA, USA.(Abstract ID 123951). Poster, Presented, 05/2023.

Grants, Contracts & Research Gifts

• Forecasting and Surveillance of Infectious Threats and Epidemics (ForeSITE) (1 NU38FT000009). PI: Matt Samore, Makoto Jones, Lindsay Keegan, Eric Lofgren, Mike Rubin. Centers for Disease Control and Prevention (CDC), 09/2024 - 09/2028. Total project budget to date: $188,646.00
• Real-World Outcomes and Healthcare Resource Utilization of Patients with Pancreatic Exocrine Insufficiency. PI: Chaiyakunapruk N. Abbott Established Pharmaceutical Division, 12/2023 - 06/2024. Total project budget to date: $180,020.00
• Comparison of treatment emergent resistance associated mutations (RAMs) among single tablet regimens or long-acting injectables for the treatment of virologically suppressed people with HIV... PI: Chaiyakunapruk N. Gilead, 11/2023 - 12/2024. Total project budget to date: $181,923.30
• Systematic Literature Review on Cost-effectiveness Analyses for Adult 15- and 20-valent Pneumococcal Vaccine. PI: Chaiyakunapruk N. Pfizer Ltd., 09/20/2023 - 03/2024. Total project budget to date: $137,579.00
• The Evaluation of Tenofovir Alafenamide Containing Regimens vs. Tenofovir Disoproxil Fumarate Containing Regimens on Renal Outcomes for Prevention and Treatment of HIV and/or HBV Treatment... PI: Chaiyakunapruk N. Gilead, 08/2023 - 06/2024. Total project budget to date: $103,981.00
• Estimating Economic Benefits of Improving Medication Adherence in Dyslipidemia. PI: Chaiyakunapruk N. Abbott Established Pharmaceutical Division, 04/2023 - 12/2023. Total project budget to date: $199,911.00
• The Role of health equity in health technology assessment: a landscape analysis of Asian countries. PI: Chaiyakunapruk N. The Equity Initiative Program under China Medical Board (CMB), 04/2023 - 10/2023. Total project budget to date: $28,050.00
• The Evaluation of the Clinical and Economic Value of Rapid Start Anti-Retroviral Therapy in Human Immunodeficiency Virus, a Literature Search. PI: Chaiyakunapruk N. Gilead, 12/2022 - 12/2023. Total project budget to date: $139,074.00
• A systematic review of equity-informative economic evaluation studies in vaccines. PI: Chaiyakunapruk N. World Health Organization (WHO), 12/2022 - 02/2023. Total project budget to date: $24,300.00
• Financial catastrophe among patients suffering from neglected tropical diseases: a systematic review of global literature. PI: Chaiyakunapruk. World Health Organization (WHO), 11/2022 - 05/2023. Total project budget to date: $10,000.00
• Effect of a State-Level Co-Payment Cap for Insulin on Utilization and Glycemic Control. PI: Chaiyakunapruk N. Agency for Health Research Quality (AHRQ), 09/2022 - 09/2023. Total project budget to date: $24,922.00
• Value of Innovation in Multiple Myeloma. PI: Chaiyakunapruk. Bristol Myers Squibb (BMS), 03/2022 - 12/2023. Total project budget to date: $343,024.00
• Research to Improve National and Global Responses to Emerging Health Threats: Accelerating the Integration of Novel Data Streams in Mathematical Modeling. PI: Matt Samore MD. Centers for Disease Control and Prevention (CDC), 09/2021 - 08/2024. Total project budget to date: $341,478.00
• Overcoming barriers to warfarin patient self-management implementation in the US healthcare system. PI: Dan Witt PharmD. Agency for Health Research Quality (AHRQ), 03/2021 - 04/2024. Total project budget to date: $53,100.00
• Estimating Public Health and Economic Implications of Increasing Access to Herpes Zoster Vaccination Rate in Community Pharmacy-Based Immunization Programs. PI: Chaiyakunapruk. ALSAM Foundation, 08/2020 - 06/2023. Total project budget to date: $100,000.00

Publications

• Li N, Panchal R, Giannouchos T, Pan RJ, Nguyen D, Nohavec R, Britton L, Chaiyakunapruk N, Biskupiak J, Wilson A, Brixner D. The impact of a statewide insulin copay cap policy for insured patients with diabetes in Utah. J Manag Care Spec Pharm. 2024;30(2):112-117. Published, 01/2024.
• Gloria MAJ, Thavorncharoensap M, Chaikledkaew U, Youngkong S, Thakkinstian A, Chaiyakunapruk N, Ochalek J, Culyer AJ. Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds. Expert Review of Pharmacoeconomics & Outcomes Research 2024;24(2):203-215. Published, 01/2024.
• Danpanichkul P, Ng CH, Muthiah M, Sparan K, Tan DJH, Duangsonk K, Sukphutanan B, Kongarin S, Harinwan N, Panpradist N, Takahashi H, Kawaguchi T, Vichitkunakorn P, Chaiyakunapruk N, Nathisuwan S, Huang D, Arab JP, Noureddin M, Mellinger JL, Wijarnpreecha K. From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women. American Journal of Gastroenterology 2023 Dec 26. doi: 10.14309/ajg.0000000000002642. Published, 12/26/2023.
• Wolfe DM, Hutton B, Corace K, Chaiyakunapruk N, Ngorsuraches S, Nochaiwong S, Presseau J, Grant A, Dowson M, Palumbo A, Suschinsky K, Skidmore B, Bartram M, Garner G, Digioacchino L, Pump A, Peters B, Konefal S, Eves AP, Thavorn K. Service-level Barriers to and Facilitators of Accessibility to Treatment for Problematic Alcohol Use: A Scoping Review. Frontier in Public Health 2023 Dec 1;11:1296239. Published, 12/01/2023.
• Akkahadsee P, Sawangjit R, Phumart P, Chaiyakunapruk N, Sakloetsakun D. Systematic review and network meta-analysis of efficacy and safety of interventions for preventing anti-tuberculosis drug induced liver injury. Scientific Reports 2023 Nov 14;13(1):19880. Published, 11/14/2023.
• Duong KNC, Le LM, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, Friedrichs M, Jones B, Pavia AT, Jones MM, Samore MH, Chaiyakunapruk N. Disparities in COVID-19 Related Outcomes in the United States by Race and Ethnicity Pre-vaccination Era: An Umbrella Review of Meta-analyses. Frontiers in Public Health 2023 Sep 7;11:1206988. Published, 09/07/2023.
• Chai-Adisaksopha C, Watanabe AH, Dilokthornsakul P, Navaravong L, Witt DM, Chaiyakunapruk N. Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillation. Sci Rep. 2023 Jul 6;13(1):10937. Published, 07/06/2023.
• Tan CJ, Patikorn C, Techasaensiri C, Pattanaprateep O, Chaiyakunapruk N. Economic and Clinical Outcomes of Pediatric Patients Under Two With Respiratory Syncytial Virus Infection in Thailand: A Real-world Retrospective Cohort Study. Pediatr Infect Dis J. 2023 Jul 4. Published, 07/04/2023.
• Ahmed A, Dujaili JA, Chuah LH, Hashmi FK, Le LK, Khanal S, Awaisu A, Chaiyakunapruk N. Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models. Appl Health Econ Health Policy. 2023 Jun 30. Published, 06/30/2023.
• Chong HY, Lim KS, Fong SL, Shabaruddin FH, Dahlui M, Mei Lai PS, Ng CC, Chaiyakunapruk N. Integrating real-world data in cost-effectiveness analysis of universal HLA-B*15:02 screening in Malaysia. British Journal of Clinical Pharmacology (In Press) 2023 Jun 9. doi: 10.1111/bcp.15818. Published, 06/09/2023.
• Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, Veettil SK, Chaiyakunapruk N. Effects of Ketogenic Diet on Health Outcomes: an Umbrella Review of Meta-analyses of Randomized Clinical Trials. BMC Med. 2023 May 25;21(1):196. Published, 05/25/2023.
• Grant A, Tan CJ, Wattanasirichaigoon S, Rungruanghiranya S, Thongphiew A, Thavorn K, Chaiyakunapruk N. Cost-effectiveness analysis of the SMART quit clinic program in smokers with cardiovascular disease in Thailand. Tob Induc Dis. 2023 Apr 5;21:47. Published, 04/05/2023.
• Duong KNC, Tan CJ, Rattanasiri S, Thakkinstian A, Anothaisintawee T, Chaiyakunapruk N. Comparison of diagnostic accuracy for diabetes diagnosis: A systematic review and network meta-analysis. Frontier in Medicine 2023 Jan 24;10:1016381. Published, 01/24/2023.
• Prasitwarachot R, Thavorn K, Patikorn C, Wattanasirichaigoon S, Rungruanghiranya S, Thongphiew A, Chaiyakunapruk N. A Cost-effectiveness Analysis of National Smoking Cessation Services among Chronic Obstructive Pulmonary Disease Patients in Thailand. Journal of Medical Economics 2023;26(1):1377-1385. Published, 01/2023.
• Phisalprapa P, Kositamongkol C, Korphaisarn K, Akewanlop C, Srimuninnimit V, Supakankunti S, Apiraksattayakul N, Chaiyakunapruk N. Cost-Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: A Real-World Evidence After Policy Implementation in Thailand. Cancers (Basel) 2023;15(20):4930. Published, 01/2023.
• Duong KNC, Nguyen DV, Chaiyakunapruk N, Nelson RE, Malone DC. Cost-Effectiveness of HLA-B*58:01 Testing to Prevent Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam. Pharmacogenomics 2023;24(13):713-724. Published, 01/2023.
• Veettil SK, Schwerer LJ, Kategeaw W, Toth D, Samore MH, Hutubessy R, Chaiyakunapruk N. A scoping review of modeling studies assessing the impact of disruptions to essential health services during COVID-19. BMJ Open 2023;13(9):e071799. Published, 01/2023.
• Mangrum JS, Saunders JA, Chaiyakunapruk N, Witt DM, King JB. A scoping review of direct oral anticoagulant ambulatory management practices. Journal of Thrombosis and Thrombolysis 2023;55(4):700-709. Published, 01/2023.
• Patikorn C, Cho JY, Lambach P, Hutubessy R, Chaiyakunapruk N. Equity-informative economic evaluations of vaccines: a systematic literature review. Vaccines (Basel) 2023;11(3):622. Published, 01/2023.
• Tan CJ, Shufelt T, Behan E, Jantara J, Koomsri C, Gordon AJ, Chaiyakunapruk N, Dhippayom T. Comparative effectiveness of psychosocial interventions in adults with harmful use of alcohol: A systematic review and network meta-analysis. Addiction 2023;118(8):1414-1429. Published, 01/2023.
• Patikorn C, Kategeaw W, Perdrizet J, Li X, Chaiyakunapruk N. Implementation Challenges and Real-World Impacts of Switching Pediatric Vaccines: A Global Systematic Literature Review. Human Vaccines & Immunotherapeutics 2023;19(1):2177459. Published, 01/2023.
• Sim R, Chong CW, Loganadan NK, Saidoung P, Adam NL, Hussein Z, Chaiyakunapruk N, Lee SW. Cost-effectiveness of glucose-lowering therapies as add-on to standard care for people with type 2 diabetes in Malaysia. Value in Health Regional Issue 2023;38:9-17. Published, 01/2023.
• Cooksey K, Veettil SK, Chaiyakunapruk N, Dhippayom T. The Potential Benefits of the TIP Framework to Characterize Health Services Interventions for Network Meta-Analysis. J Evid Based Med 2023;16(2):123-5. Published, 01/2023.
• Watanabe AH, Veettil SK, Le LM, Bald E, Tak C, Chaiyakunapruk N. Clinical and Economic Implications of Increasing Access to Herpes Zoster Vaccination Rate in Community Pharmacies. Journal of American Pharmaceutical Association; 2023: 17:S1544-3191(23)00153-X. Published, 01/2023.
• Dhippayom T, Rattanachaisit N, Wateemongkollert A, Napim R, Chaiyakunapruk N. Should CINAHL be used as one of the main databases for evidence synthesis of health services intervention? Cochrane Evidence Synthesis and Methods. 2023;e12019. doi:10.1002/cesm.12019. Published, 01/2023.
• Veettil SK, Kategeaw W, Hejazi1 A, Workalemahu T, Rothwell E, Silver RM, Chaiyakunapruk N. The economic burden associated with stillbirth: A systematic review. Birth 2023;50(2):300-309. Published, 01/2023.
• Syeed MS, Nonthasawadsri T, Nelson R, Chaiyakunapruk N. Nathisuwan S. Integrating Real-world Evidence in Economic Evaluation of Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation in a Developing Country. American Journal of Cardiovascular Drugs 2023;23(2):173-183. Published, 01/2023.
• Sawangjit R, Chuenchom C, Sanverm T, Chaiyakunapruk N, Jiranukool J, Nithipaijit R, Sadoyu S, Phianchana C, Jinatongthai P. Efficacy and safety of herbal medicine on dementia and cognitive function: An umbrella review of systematic reviews and meta-analysis. Phytotherapy Research 2023;37(6):2364-2380. Published, 01/2023.
• Danpanichkul P, Kongarin S, Permpatdechakul S, Polpichai N, Duangsonk K, Manosroi W, Chaiyakunapruk N, Mousa OY, Kim D, Chen VL, Wijarnpreecha K. The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019. Journal of Clinical Medicine 2023;12(20):6456. Published, 01/2023.
• Veetil SK, Vincent V, Shufelt T, Behan E, Syeed MS, Thakkinstian A, Young D, Chaiyakunapruk N. Incremental Net Monetary Benefit of Biologic Therapies in Moderate to Severe Asthma: A Systematic Review and Meta-Analysis of Economic Evaluation Studies. Journal of Asthma 2023;60(9):1702-1714. Published, 01/2023.
• Kategeaw W, Nakkam N, Kiertiburanakul S, Sukasem C, Tassaneeyakul W, Chaiyakunapruk N. Cost-effectiveness Analysis of HLA-B*13:01 Screening for the Prevention of Co-trimoxazole-induced Severe Cutaneous Adverse Reactions among HIV-infected Patients in Thailand. Journal of Medical Economics 2023;26(1):1330-1341. Published, 01/2023.
• Dilokthornsakul P, Thomas D, Brown L, Chaiyakunapruk N. Chapter 19: Interpreting Pharmacoeconomic Findings. Book: Clinical Pharmacy, Education, Practice and Research. Editor: Dixon Thomas, Elsvier Publication, 2019. Page 277-287. Published, 01/2019.
• Beutels P, Bilcke J, Jit M, Chaiyakunapruk N, Hutubessy R. WHO guide for standardization of economic evaluations of immunization programmes, 2nd edition: World Health Organization; 2019(https://apps.who.int/iris/bitstream/handle/10665/329389/WHO-IVB-19.10-eng.pdf accessed 27 July 2021). Published, 01/2019.
• Newall AT, Chaiyakunapruk N, Kotirum S, Lambach P, Hutubessy RCW. Guidance on the economic evaluation of influenza vaccination: World Health Organization; 2017(http://apps.who.int/iris/bitstream/10665/250086/1/WHO-IVB-16.05-eng.pdf?ua=1 accessed 25 December 2017). Published, 12/25/2017.
• Chaiyakunapruk N, Kotirum S, Newall AT, Lambach P, Hutubessy RCW. WHO Manual for estimating the economic burden of seasonal influenza: World Health Organization; 2017(http://apps.who.int/iris/bitstream/10665/250085/1/WHO-IVB-16.04-eng.pdf?ua=1, accessed 25 December 2017). Published, 12/25/2017.
• Saokaew S, Samparsit N, Kulchaitanaroaj P, Chaiyakunapruk N. Economic evaluation of pharmacy services. 1^st ed. London: Elsvier, 2017. Chapter 9: Economic evaluation of pharmacist-managed warfarin therapy: a review of studies; p. 193- 214. Published, 01/2017.
• Chaiyakunapruk N, Hadnorntun P, Saksinanon A. Excellent Pharmacy Practice in Cardiovascular Diseases. 1^st ed. Chiangmai: Chiangmai University Press, 2017. Chapter 1: Implementing Research in Cardiovascular Diseases: Area for Pharmacists; p.1-9. . Published, 01/2017.